Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2.

MLA

Macarulla, Teresa, et al. “Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 37, no. 3, Jan. 2019, pp. 230–38. EBSCOhost, https://doi.org/10.1200/JCO.18.00089.

APA

Macarulla, T., Pazo-Cid, R., Guillén-Ponce, C., López, R., Vera, R., Reboredo, M., Muñoz Martin, A., Rivera, F., Díaz Beveridge, R., La Casta, A., Martín Valadés, J., Martínez-Galán, J., Ales, I., Sastre, J., Perea, S., & Hidalgo, M. (2019). Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 37(3), 230–238. https://doi.org/10.1200/JCO.18.00089

Chicago

Macarulla, Teresa, Roberto Pazo-Cid, Carmen Guillén-Ponce, Rafael López, Ruth Vera, Margarita Reboredo, Andrés Muñoz Martin, et al. 2019. “Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 37 (3): 230–38. doi:10.1200/JCO.18.00089.